Mainstream

Dexcom Signals 14% Revenue Growth Target For 2025 With New Product Launches And Expanded Coverage

DexCom signals 14% revenue growth target for 2025 with new product launches and expanded coverage

DexCom signals 14% revenue growth target for 2025 with new product launches and expanded coverage

Post ContentdxcmRead More

You might also be interested in reading Alcon to buy STAAR Surgical for $28 per share.

February 14, 2025
In Mainstream